Achilles Therapeutics plc (ACHL)
Achilles Therapeutics Plc is a biopharmaceutical company engaged in developing transformative precision T-cell therapies to treat multiple types of solid tumors. It focuses on researching, developing and commercializing potentially novel cancer immunotherapies targeting clonal neoantigens. The company was founded by Karl Peggs, Sergio Quezada, Mark Lowdell and Charles Swanton in November 2020 and is headquartered in London, the United Kingdom.
Address
245 HAMMERSMITH ROAD
LONDON, X0 W6 8PW
Founded
2020
Number of Employees
215
Website
http://www.achillestx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)